A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Sponsor: City of Hope Medical Center
Los Angeles, CA · San Francisco, CA · +9 more sites
16 recruiting type 2 diabetes studies with a site in Los Angeles, CA.
Sponsor: City of Hope Medical Center
Los Angeles, CA · San Francisco, CA · +9 more sites
Sponsor: Novo Nordisk A/S
Fountain Valley, CA · Long Beach, CA · Los Angeles, CA · +22 more sites
Sponsor: Hoffmann-La Roche
Los Angeles, CA · +1 more sites
Sponsor: Ascletis Pharma (China) Co., Limited
Banning, CA · Chula Vista, CA · Covina, CA · +81 more sites
Sponsor: AstraZeneca
Bakersfield, CA · Los Angeles, CA · Ontario, CA · +37 more sites
Sponsor: Eli Lilly and Company
Los Angeles, CA · San Francisco, CA · +38 more sites
Sponsor: Insulet Corporation
Los Angeles, CA · Santa Barbara, CA · +9 more sites
Sponsor: Brigham and Women's Hospital
Los Angeles, CA · +35 more sites
Sponsor: Sanofi
Los Angeles, CA · San Francisco, CA · +35 more sites
Sponsor: University of California, Los Angeles
Los Angeles, CA
Sponsor: University of California, Los Angeles
Los Angeles, CA
Sponsor: Children's Hospital Los Angeles
Los Angeles, CA
Sponsor: Children's Hospital Los Angeles
Los Angeles, CA · San Francisco, CA
Sponsor: Tides Medical
Fresno, CA · Los Angeles, CA · +6 more sites
Sponsor: University of California, Los Angeles
Los Angeles, CA
Sponsor: Eli Lilly and Company
Los Alamitos, CA · Los Angeles, CA · +23 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.